A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty

Information

• Research Project
• 9853185

• ApplicationId

  9853185

• Core Project Number

  R44AG062015

• Full Project Number

  4R44AG062015-02

• Serial Number

  062015

• FOA Number

  PAR-18-183

• Sub Project Id

• Project Start Date

  9/30/2018 - 5 years ago

• Project End Date

  2/28/2021 - 3 years ago

• Program Officer Name

  ROMASHKAN, SERGEI

• Budget Start Date

  5/1/2019 - 5 years ago

• Budget End Date

  2/28/2020 - 4 years ago

• Fiscal Year

  2019

• Support Year

  02

• Suffix

• Award Notice Date

  4/26/2019 - 5 years ago

Organizations

• Longeveron Inc.

IC Name

• Activity

  R44

• Administering IC

  AG

• Application Type

  4

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  1983531

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  866

• Ed Inst. Type

• Funding ICs

  NIA:1983531\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  LONGEVERON, LLC

• Organization Department

• Organization DUNS

  079689775

• Organization City

  MIAMI

• Organization State

  FL

• Organization Country

  UNITED STATES

• Organization Zip Code

  331361112

• Organization District

  UNITED STATES